"10.1371_journal.pone.0033084","plos one","2012-03-16T00:00:00Z","Harald J√∂rn Schneider; Henri Wallaschofski; Henry V√∂lzke; Marcello Ricardo Paulista Markus; Marcus Doerr; Stephan B Felix; Matthias Nauck; Nele Friedrich","Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany; Medizinische Klinik - Innenstadt, Klinikum der Universit√§t, Munich, Germany; Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany; Department of Cardiology, Ernst Moritz Arndt University Greifswald, Greifswald, Germany","Conceived and designed the experiments: HJS NF HW. Performed the experiments: HV HW MD MN. Analyzed the data: HJS HW HV MM MD SBF MN NF. Contributed reagents/materials/analysis tools: HV HW. Wrote the paper: HJS. Critically revised manuscript for important intellectual content: HJS HW HV MM MD SBF MN NF.","Harald J. Schneider received research grants from Pfizer, travel grants from Novartis, Pfizer, and Lilly, speaker fees from Novo Nordisk and Pfizer, and is a member of the German KIMS (Pfizer International Metabolic Survey) board, a scientific advisory board evaluating the effects of growth-hormone replacement in hypopituitarism sponsored by Pfizer. Henri Wallaschofski received research grants from Pfizer and Novo Nordisc and is member of the German KIMS (Pfizer International Metabolic Survey) board, a scientific advisory board evaluating the effects of growth-hormone replacement in hypopituitarism sponsored by Pfizer. Henry V√∂lzke, Marcus D√∂rr, Marcelo Markus, Stephan B. Felix, Mathias Nauck, and Nele Friedrich report no conflict of interest. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Harald J√∂rn Schneider","HJ√S",8,TRUE,3,4,8,1,TRUE,TRUE,FALSE,0,NA,FALSE
